Treatment of Extrapapillary Retinal Hemangioblastoma (1.5–4.5 mm) After Thermal Laser Photocoagulation Has Not Achieved Adequate Tumor Control
Clinical Scenario
This protocol is for extrapapillary retinal hemangioblastoma measuring between 1.5 and 4.5 mm in diameter — a size range in which complete tumor destruction using thermal laser photocoagulation is often particularly difficult to achieve.
Prior Treatment & Reason for Escalation
Thermal laser photocoagulation — applied as long-duration burns over multiple sessions — was used as the initial approach. Adequate treatment response is indicated by a decrease in tumor size and vascularity, resolution of subretinal fluid and hard exudation, normalization of feeder vessel caliber, reduction in vessel tortuosity, and formation of an underlying chorioretinal scar. When these signs of adequate destruction are not achieved, a subsequent treatment step is indicated.
Next Treatment Approach (Overview Only)
For lesions in this size range that are refractory to laser photocoagulation, a cryotherapy-based intervention directed at the tumor is the approach — the specific technique, application method, and any adjunctive measures are detailed in the full protocol.
Treatment Goals
- Significant reduction in tumor size with fibrotic change
- Marked decrease in dilation and tortuosity of feeding and draining vessels
- Improvement of macular edema and lipid deposition by approximately five months
References
DOI: 10.1097/IAE.0000000000002572
- Extrapapillary RH between 1.5 and 4.5 mm in diameter are more difficult to destroy using thermal laser photocoagulation.
- Trans-scleral cryotherapy is often effective for RH in this size range, either as treatment applied to lesions refractory to previous laser photocoagulation, or as first-line therapy.
- Treatment can be applied trans-conjunctivally for anterior tumors, or trans-sclerally after conjunctival incision to enable appropriate probe placement for more posterior lesions.
- The technique varies, with some using a single freeze-thaw cycle (typically in the context of treating tumors already partly-regressed from prior laser photocoagulation, and others using a double freeze-thaw method.
- Five months after cryotherapy, the tumor is significantly smaller and its temporal aspect appears fibrotic.
- Feeding/draining vessels are much less dilated and tortuous.
- Macular edema and lipid have improved.
View source ↗